Atropine for Myopia Control: How It Works and What the Research Shows

How Does Atropine Slow Myopia?

Atropine slows myopia by changing the thought to influence retinal signalling that regulates axial elongation. In people with progressive short-sightedness, the eye can continue to elongate over time. Low-dose atropine helps slow that process, which may reduce the long-term risk of eye health complications linked with higher myopia.

At The Focal Point Optometrist, we view myopia management as a critical healthcare service rather than a simple retail transaction. Our approach is rooted in the latest clinical evidence, ensuring that every patient in Wembley and the surrounding Western Australian community receives a tailored plan that prioritises their long-term visual health.

Key Takeaways:

  • Atropine is used to slow the progression of myopia by reducing biochemical signals that drive excessive eye growth.
  • Current evidence supports low-dose atropine between 0.025% and 0.05% as the most effective range, with 0.05% showing the strongest effect in major clinical trials.
  • 0.01% is generally less effective, though it may still be used in some cases for tolerability. It is the only widely commercially available strength in some markets, while higher doses are typically compounded in Australia.
  • Treatment is monitored using changes in prescription and axial length to track true eye growth.
  • Myopia management is individualised and often combines atropine with optical treatments such as contact lenses or specialised spectacles.

Myopia is more than just a need for spectacles: it is a structural change in the eye. When the eyeball grows too long, the tissues at the back of the eye are stretched and thinned. This stretching is what leads to a higher risk of sight-threatening conditions later in life. By intervening early with treatments like low-dose atropine, we aim to slow this elongation. This is particularly important for children and young adults whose eyes are still developing and are most susceptible to rapid changes in their prescription.

At our practice, we focus on the biological drivers of this growth to provide a more comprehensive level of care. Initial consultations are typically around an hour, allowing time for a detailed assessment, including measurements such as axial length to monitor eye growth. We aim to provide clear explanations so patients understand their options and what to expect moving forward.

How Does Atropine Slow Myopia? Understanding the Biological Mechanism

Atropine slows myopia by influencing the biological signals that control eye growth. It does not simply sharpen vision or act like a pair of spectacles. Instead, it works within the eye to reduce the tendency for the eyeball to elongate over time.

For many years, atropine was thought to work mainly by relaxing the eye’s focusing system, known as accommodation. Researchers now understand that this is only part of the story. Evidence suggests its main effect is on tissues at the back of the eye, particularly the retina, choroid, and sclera. The process of eye growth is regulated by a complex cascade of chemical messengers. When the eye detects that an image is not focusing correctly on the retina, it sends signals to the sclera (the white outer wall) to grow and compensate. Atropine appears to intercept these signals, effectively telling the eye to stop growing so quickly.

Blocking growth signals in the eye

One of the main ways atropine works is by blocking certain receptors in the eye. These receptors are found in different parts of the eye, including the retina and the outer wall (sclera). When these receptors are blocked, the chain of signals that encourages the eye to grow becomes less active.

In short-sighted eyes, the outer wall can become more stretchy over time. Atropine may influence scleral remodelling, which is a big shift in treatment. Instead of just correcting blurry vision, we’re actually helping manage how the eye grows.

Supporting healthy eye function and blood flow

Atropine may also support natural chemical systems inside the eye. One of these involves dopamine, a chemical that helps regulate eye growth. Higher retinal dopamine activity has been associated with slower eye growth in myopia research, and atropine has been proposed as one of several possible mechanisms.

Choosing the Correct Atropine Concentration

Selecting the most appropriate atropine concentration involves carefully balancing treatment effectiveness with comfort and potential visual side effects. The goal is to slow myopia progression as effectively as possible while maintaining good day-to-day visual function.

Recent high-quality clinical research, including the LAMP study, has shown that 0.05% atropine provides the strongest level of control over myopia progression among commonly used low-dose options. A concentration of 0.025% offers a middle ground, delivering moderate effectiveness while generally being well tolerated. In comparison, 0.01% atropine has a smaller overall treatment effect and is now considered less effective for controlling progression, although it may still be used in certain cases where tolerability is the primary concern.

Based on current evidence, concentrations between 0.025% and 0.05% are widely regarded as the most effective low-dose range for slowing myopia progression in children and young adults.

In Australia, availability varies depending on formulation. The 0.01% strength may be commercially available in some settings, whereas higher concentrations such as 0.025% and 0.05% are typically prepared through compounding pharmacies to ensure precise dosing and clinical suitability.

At The Focal Point Optometrist, the selection of atropine concentration is individualised. We consider the patient’s rate of myopia progression, their stage of eye development, and their everyday visual demands, including school, work, and sporting activities. We also take into account how sensitive the patient is to potential side effects such as mild blur or light sensitivity, ensuring the treatment plan is both effective and practical for long-term use.

Light Sensitivity and Pupil Effects

Atropine works in part by causing a slight dilation of the pupil (mydriasis) and reducing the eye’s ability to focus up close (accommodation). These changes are generally mild at low doses but can still influence how the eyes respond to light and near tasks.

As a result, some patients may experience increased light sensitivity (photophobia), particularly in bright outdoor environments. Mild glare is also possible, especially under strong sunlight or reflective conditions. In some cases, particularly at higher concentrations, there may be a slight difficulty with near focusing, such as reading or detailed close work.

These effects are typically dose-dependent, meaning they become more noticeable as the concentration of atropine increases.

Importantly, patients with lighter-coloured irides, such as blue or light hazel eyes, may notice greater light sensitivity. This is because lighter irises provide less natural filtering of incoming light, making the pupil dilation effect more noticeable in bright conditions.

To manage these effects, several practical strategies can be helpful. Wearing UV-blocking sunglasses outdoors can significantly reduce glare and improve comfort. Photochromic (transition) lenses may also provide a convenient option by automatically adjusting to changing light conditions. In some cases, adjusting the atropine concentration can further help balance treatment effectiveness with visual comfort.

Comparing Atropine to Spectacles and Contact Lenses

modern spectacles next to a contact lens case - how does atropine slow myopia

Atropine is one option for myopia management, but it’s not the only one. Depending on your needs, we may recommend atropine on its own or combine it with optical options to improve overall control. The choice often depends on lifestyle, age, and the specific rate of eye growth we observe during your consultation.

  • Orthokeratology (Ortho-K): This uses specially designed rigid contact lenses worn overnight to reshape the cornea temporarily. This provides clear vision during the day without spectacles or lenses. Some studies suggest that combining Orthokeratology for Myopia Control with low-dose atropine may slow progression more than either approach alone. This dual-action strategy addresses both the optical and chemical drivers of eye growth.
  • Multifocal spectacles: Certain lens designs aim to reduce peripheral defocus signals linked with eye growth. These can be a good option for children or adults who would prefer not to use drops alone or who do not want contact lenses. These lenses are designed to provide clear central vision while managing the signals at the edge of the retina.
  • MiSight lenses: These soft contact lenses use dual-focus optics to provide clear vision while also helping manage progression. You can read more about MiSight Contact Lenses for Myopia Management and how they compare with atropine. They are a popular choice for active children who play sports.
  • Lifestyle habits: We also talk about everyday visual habits. More time outdoors and regular breaks from prolonged near work may support healthier visual development and reduce visual strain. We recommend at least 90 to 120 minutes of outdoor time daily to help the eyes receive natural light signals.

This part of the treatment is not about choosing the most complicated option. It is about finding a practical plan that suits your eyes, your routine, and your long-term goals. We walk you through each option during your consultation at The Focal Point Optometrist so you can make a decision that feels right for you and your family.

Pre-Myopia and the Role of Atropine in High-Risk Children

Atropine may also be considered for children who are not yet short-sighted but are identified as being at high risk of developing myopia (pre-myopia). These patients typically have early signs such as shorter-than-expected focusing ability for their age, a strong family history of myopia, or measurable patterns of faster-than-normal eye growth. In these cases, atropine may be used as a preventative or early-intervention strategy under close clinical monitoring to help slow the onset of myopia.

Current research suggests that early intervention in high-risk children may help delay or reduce the likelihood of myopia development, particularly when combined with lifestyle strategies such as increased outdoor time and reduced sustained near work. However, treatment decisions are made on a case-by-case basis, as not all pre-myopic children will require pharmacological intervention.

Importantly, atropine is used to slow or prevent the progression of myopia but does not correct refractive error. This means that even when atropine is prescribed, children who are already short-sighted will still require appropriate optical correction, such as spectacles, contact lenses, or orthokeratology lenses, to achieve clear vision in daily life.

Administering Atropine Drops Correctly

Consistency is the most important factor in pharmacological myopia management. Following a reliable routine ensures the medication maintains a steady effect on the eye’s growth signals. If drops are missed frequently, the braking effect on the eye’s elongation is diminished, which can lead to faster progression. We recommend making the drops part of your nightly routine, much like brushing your teeth.

  • Daily application: We generally recommend applying the drops once daily at bedtime. This allows any minor blurring or pupil dilation to occur while you sleep, minimising the impact on your daily activities. Use a single drop in each eye. By applying them at night, you ensure the medication is absorbed while the eye is at rest.
  • Hygiene and storage: Always wash your hands before handling the bottle. Ensure the dropper tip does not touch your eye, eyelashes, or any other surface to prevent contamination. Store the bottle according to the pharmacist’s instructions, usually in a cool, dry place away from direct sunlight. Some formulations may require refrigeration, so always check the label.
  • Monitoring progress: Success is measured through regular eye tests. At The Focal Point Optometrist, we do not just check your script: we use advanced technology to measure your axial length (the actual length of your eyeball). This is the most accurate way to see if the atropine is working. If you’d like a deeper look into how this is managed long-term, you can explore our guide on Adult Myopia Atropine – What You Need to Know.
  • Script adjustments: If the eye continues to grow at an undesirable rate, we may increase the concentration. Conversely, if progression has stabilised for a significant period (usually several years), we may discuss tapering the treatment. This involves slowly reducing the frequency of the drops rather than stopping abruptly, which helps prevent a rebound in growth. We monitor these transitions closely to ensure the eye remains stable.

Managing Side Effects and Long-Term Eye Health

While low-dose atropine is generally very well tolerated, we monitor for minor side effects to ensure the treatment does not interfere with your quality of life. Because we spend a full hour during initial consultations at The Focal Point Optometrist, we have the time to discuss these potential issues in detail and provide practical solutions for managing them.

  • Light sensitivity: Atropine can cause slight pupil dilation. While these effects are generally mild at lower concentrations, some patients may still notice increased glare in the bright Australian sunlight. The solution is simple: high-quality UV protection. We often recommend photochromic lenses (spectacles that darken automatically outdoors) to provide seamless comfort and protect the internal structures of the eye from UV damage. This effect may be more noticeable in patients with lighter-coloured irides, such as blue or light hazel eyes, due to reduced natural light filtering.
  • Near vision blur: Because atropine relaxes the focusing muscles, some people might find that very fine print becomes slightly blurry. This is rare with low doses, but if it occurs, we can adjust the concentration or prescribe a mild pair of reading spectacles or multifocal lenses to use for extended desk work or school tasks.
  • Systemic safety: One of the reasons we favour low-dose atropine is its excellent safety profile. Because the concentration is so low, very little of the medication is absorbed into the bloodstream. Long-term data from the LAMP study safety profile and the 5-year ATOM2 follow-up confirm that these doses are safe for long-term use in children and adults.
  • Preventing complications: The ultimate goal of answering how does atropine slow myopia is to protect your future vision. By slowing eye growth, we significantly reduce your lifetime risk of:
    • Glaucoma: A condition where high pressure damages the optic nerve, which is more common in highly short-sighted eyes.
    • Retinal detachment: Where the retina pulls away from the back of the eye, a medical emergency that is more likely when the eye is elongated.
    • Cataracts: Short-sighted individuals tend to develop cataracts earlier in life, and managing myopia can help delay this.
    • Myopic macular degeneration: Damage to the central vision caused by stretching of the macula, which cannot be fully corrected with spectacles.

Practical Solutions for Myopia Management

At The Focal Point Optometrist, we believe that successful myopia management requires a combination of clinical treatment and practical lifestyle adjustments. While atropine is a powerful tool, it works best when supported by healthy visual habits. We work with our patients to create a holistic plan that fits into their daily lives without feeling like a burden.

One of the most effective practical solutions is increasing the time spent outdoors. Research consistently shows that children who spend at least two hours outside each day have a lower risk of developing myopia and slower progression if they are already short-sighted. The bright, full-spectrum light found outdoors triggers the release of dopamine in the retina, which acts as a natural signal to slow eye growth. We encourage families in Wembley to make outdoor play or walking a regular part of their routine.

Another key area is managing near-work habits. In our modern world, we spend a significant amount of time looking at screens and books. We recommend the 20-20-20 rule: every 20 minutes, look at something 20 feet (about 6 metres) away for at least 20 seconds. This helps to relax the focusing muscles and reduce the strain on the eye. Additionally, maintaining a proper working distance (about the length of your forearm) and ensuring good lighting during reading can make a significant difference.

At The Focal Point Optometrist, we provide personalised advice on how to optimise your environment for better eye health.

We also emphasise the importance of regular follow-up appointments. Myopia management is an ongoing process, not a one-time fix. By monitoring axial length and prescription changes every six months, we can see exactly how the eye is responding to treatment. This data-driven approach allows us to make informed adjustments to the atropine concentration or combine it with other optical solutions if needed. Our goal is to provide a proactive service that stays ahead of the changes in your vision.

A Clearer Path Forward: Partnering with The Focal Point Optometrist

We believe myopia care should feel clear, thorough, and supportive. We are a family-oriented practice in Wembley, Western Australia, and we focus on healthcare first. That means taking time to understand your history, measure what matters, explain the science in plain language, and build a plan that suits your life. We are committed to providing the highest standard of care for our community, ensuring that every patient feels heard and valued.

Our initial consultations are usually 1 hour, which gives us the time to properly assess your vision, discuss treatment options, and answer questions without rushing. We use detailed monitoring, including axial length where appropriate, so we are not simply checking whether your script has changed. We are looking at how your eyes are changing over time and what we can do to help slow that process. This comprehensive approach is what sets The Focal Point Optometrist apart: we are invested in your long-term visual outcomes.

If you are considering atropine for short-sightedness, we are here to guide you through it step by step. We understand that starting a new treatment can feel overwhelming, but our team is here to provide the support and expertise you need. We will monitor your progress closely and make adjustments as necessary to ensure the best possible results. Please remember to bring your Medicare card to your appointment so we can facilitate your visit efficiently.

Book an eye test with our expert team today

FAQs

Does myopia progression rebound after stopping atropine?

A rebound effect can happen, which means myopia may start progressing more quickly after treatment stops. This appears to be more noticeable with higher concentrations. To reduce that risk, we generally prefer a gradual taper rather than stopping suddenly, along with regular follow-up visits to monitor your script and axial length. At The Focal Point Optometrist, we carefully manage the cessation of treatment to ensure stability.

Can atropine be used alongside contact lenses?

Yes. Atropine is often used together with contact lenses as part of a broader myopia management plan. In many cases, the drops are used at bedtime after contact lenses have been removed. If you are using Ortho-K, we will give you specific instructions so the timing is clear and safe. This combination can often provide superior results for rapidly progressing cases.

How long does it take to see results from atropine?

Myopia control takes time, so we usually assess progress over months rather than days or weeks. Review points at 6 and 12 months are common, and axial length measurements are especially helpful in showing whether treatment is slowing eye growth. We look for a reduction in the rate of change compared to previous years.

Is low-dose atropine safe for long-term use?

Current research suggests low-dose atropine has a good safety profile when used under optometric supervision. Some people notice mild glare or slightly reduced near focusing, but these effects are generally manageable. We monitor for side effects carefully and adjust the plan if needed. Long-term studies have followed patients for several years with no significant safety concerns.

Can adults benefit from atropine for myopia?

Yes. While much of the research has focused on younger populations, adults with progressive myopia may also benefit from low-dose atropine. We assess each person individually and use axial length measurements alongside script changes to determine whether treatment is appropriate and effective. If your prescription is still changing in your 20s or 30s, it is worth discussing this option with us.

What happens if I miss a dose of atropine?

If you miss a single dose, simply continue with your regular routine the following night. Do not apply a double dose to make up for the missed one. Consistency is key, so try to keep the bottle in a visible place to help you remember. If you find you are missing doses frequently, let us know so we can discuss strategies to help you stay on track.

When should I seek other medical care?

If you develop sudden vision loss, flashes of light, a curtain over your vision, pain, or other urgent symptoms, you should seek prompt medical attention. If a surgical opinion is needed, we may refer you to an ophthalmologist. If treatment outside eye care is required, such as oral antibiotics for a separate infection, your General Practitioner (GP) is the right person to see.

  • Monday : 8:30 AM - 5:00 PM
  • Tuesday : 8:30 AM - 5:00 PM
  • Wednesday : 8:30 AM - 5:00 PM
  • Thursday : 8:30 AM - 5:00 PM
  • Friday : 8:30 AM - 5:00 PM
  • Saturday : Closed
  • Sunday : Closed